ZA979327B
(en)
*
|
1996-10-18 |
1998-05-11 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease.
|
JP2001508767A
(ja)
*
|
1996-12-02 |
2001-07-03 |
藤沢薬品工業株式会社 |
5―ht拮抗作用を有するインドール―ウレア誘導体
|
EP1366766A1
(en)
*
|
1997-03-14 |
2003-12-03 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6093742A
(en)
*
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
SK5462000A3
(en)
|
1997-10-31 |
2001-02-12 |
Aventis Pharma Ltd |
Substituted anilides
|
HUP0101704A3
(en)
*
|
1997-12-22 |
2002-12-28 |
Bayer Corp Pittsburgh |
Kinease substituted heterocyclic ureas with raf inhibition activity and pharmaceutical compositions containing them
|
DK1043995T3
(da)
*
|
1997-12-22 |
2007-03-05 |
Bayer Pharmaceuticals Corp |
Inhibering af p38 kinaseaktivitet ved anvendelse af aryl- og heteroaryl-substituerede, heterocykliske urinstoffer
|
AU3665199A
(en)
*
|
1998-04-29 |
1999-11-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of impdh enzyme
|
DE69915472T2
(de)
*
|
1998-06-04 |
2004-08-19 |
Kumiai Chemical Industry Co., Ltd. |
Phenylacetylenderivate und bakterizide für landwirtschaft und gartenbau
|
CA2342626A1
(en)
*
|
1998-10-22 |
2000-05-04 |
Neurosearch A/S |
Substituted phenyl derivatives, their preparation and use
|
US6420403B1
(en)
|
1998-10-29 |
2002-07-16 |
Edwin J. Iwanowicz |
Inhibitors of IMPDH enzyme
|
EP1127054A4
(en)
|
1998-10-29 |
2006-11-02 |
Bristol Myers Squibb Co |
INHIBITORS OF IMPDH ENZYME
|
US6596747B2
(en)
|
1998-10-29 |
2003-07-22 |
Bristol-Myers Squibb Company |
Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
|
JP2002528499A
(ja)
|
1998-10-29 |
2002-09-03 |
ブリストル−マイヤーズ スクイブ カンパニー |
Impdh酵素のインヒビターであるアミノ核誘導化合物
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
DE69917673T2
(de)
*
|
1998-12-09 |
2005-06-09 |
Wyeth |
Alpha-methylbenzyl-enthaltende thioharnstoffe als inhibitoren von herpes-viren mit einer phenylenediamingruppe
|
US6166028A
(en)
|
1998-12-09 |
2000-12-26 |
American Home Products Corporation |
Diaminopuridine-containing thiourea inhibitors of herpes viruses
|
US6262090B1
(en)
|
1998-12-09 |
2001-07-17 |
American Home Products Corporation |
Aminopyridine-containing thiourea inhibitors of herpes viruses
|
US6201013B1
(en)
|
1998-12-09 |
2001-03-13 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
|
PL348178A1
(en)
*
|
1998-12-09 |
2002-05-06 |
American Home Prod |
Thiourea inhibitors of herpes viruses
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
WO2000037434A1
(fr)
*
|
1998-12-22 |
2000-06-29 |
Mitsubishi Chemical Corporation |
Derives d'amide
|
IL144144A0
(en)
|
1999-01-13 |
2002-05-23 |
Bayer Ag |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
EE04799B1
(et)
*
|
1999-03-12 |
2007-04-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
|
EE200100492A
(et)
*
|
1999-03-19 |
2002-12-16 |
Vertex Pharmaceuticals Incorporated |
Ensüümi IMPDH inhibiitorid
|
US6653309B1
(en)
|
1999-04-26 |
2003-11-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme technical field of the invention
|
AU5031200A
(en)
*
|
1999-05-28 |
2000-12-18 |
Vertex Pharmaceuticals Incorporated |
Method for preparing 5-substituted oxazoles
|
US6107052A
(en)
*
|
1999-06-09 |
2000-08-22 |
Roche Diagnostics Corporation |
Enzymatic measurement of mycophenolic acid
|
WO2001000622A1
(en)
*
|
1999-06-25 |
2001-01-04 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of carbamate inhibitors of impdh
|
JP2001011060A
(ja)
*
|
1999-06-28 |
2001-01-16 |
Nippon Synthetic Chem Ind Co Ltd:The |
新規オキサゾール化合物及びその製造方法
|
JP2001011059A
(ja)
*
|
1999-06-28 |
2001-01-16 |
Nippon Synthetic Chem Ind Co Ltd:The |
5−(2−置換−4−ニトロフェニル)−オキサゾールの製造方法
|
TWI262185B
(en)
*
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
US6867299B2
(en)
|
2000-02-24 |
2005-03-15 |
Hoffmann-La Roche Inc. |
Oxamide IMPDH inhibitors
|
AU2001255538B2
(en)
|
2000-04-24 |
2006-03-30 |
Bristol-Myers Squibb Company |
Heterocycles that are inhibitors of IMPDH enzyme
|
SV2003000617A
(es)
*
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US6423849B1
(en)
*
|
2000-09-01 |
2002-07-23 |
The Nippon Synthetic Chemical Industry Co., Ltd. |
Process of preparing 5-(2-substituted-4-nitrophenyl)-oxazole, novel oxazole compound, and process of preparing the same
|
US6593362B2
(en)
*
|
2001-05-21 |
2003-07-15 |
Guilford Pharmaceuticals Inc. |
Non-peptidic cyclophilin binding compounds and their use
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
EP2324825A1
(en)
|
2002-02-11 |
2011-05-25 |
Bayer Healthcare LLC |
Aryl ureas with angiogenesis inhibiting activity
|
US8110587B2
(en)
|
2002-02-11 |
2012-02-07 |
Bayer Healthcare Llc |
Aryl ureas as kinase inhibitors
|
EP1402887A1
(en)
*
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
AU2003298868B2
(en)
*
|
2002-12-06 |
2009-09-17 |
Vertex Pharmaceuticals Incorporated |
Compositions comprising a combination of diphenyl ura IMPDH inhibitors and apoptosis-inducing anti-cancer agents
|
AU2003300076C1
(en)
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
US7220768B2
(en)
*
|
2003-02-11 |
2007-05-22 |
Wyeth Holdings Corp. |
Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
|
ATE384264T1
(de)
|
2003-05-20 |
2008-02-15 |
Bayer Pharmaceuticals Corp |
Diaryl-harnstoffe mit kinasehemmender wirkung
|
NZ580384A
(en)
|
2003-07-23 |
2011-03-31 |
Bayer Pharmaceuticals Corp |
4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
|
TWI359147B
(en)
*
|
2003-09-05 |
2012-03-01 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hcv n
|
AU2004282148A1
(en)
|
2003-10-10 |
2005-04-28 |
Vertex Pharmaceuticals Incoporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
AR045870A1
(es)
*
|
2003-10-11 |
2005-11-16 |
Vertex Pharma |
Terapia de combinacion para la infeccion de virus de hepatitis c
|
AU2004285019B9
(en)
|
2003-10-27 |
2011-11-24 |
Vertex Pharmaceuticals Incorporated |
HCV NS3-NS4A protease resistance mutants
|
EP1944042A1
(en)
|
2003-10-27 |
2008-07-16 |
Vertex Pharmceuticals Incorporated |
Combinations for HCV treatment
|
CA2554999A1
(en)
|
2004-02-04 |
2005-08-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
US7317030B2
(en)
|
2004-02-26 |
2008-01-08 |
4Sc Ag |
Compounds as inhibitors of cell proliferation and viral infections
|
EP1568696A1
(en)
*
|
2004-02-26 |
2005-08-31 |
4Sc Ag |
Compounds as inhibitors of cell proliferation and viral infections
|
EP1768662A2
(en)
|
2004-06-24 |
2007-04-04 |
Novartis Vaccines and Diagnostics, Inc. |
Small molecule immunopotentiators and assays for their detection
|
PL1778686T3
(pl)
|
2004-08-12 |
2009-04-30 |
Pfizer |
Pochodne triazolopirydynylosulfanylowe jako inhibitory kinazy MAP P38
|
AU2005291918A1
(en)
|
2004-10-01 |
2006-04-13 |
Vertex Pharmaceuticals Incorporated |
HCV NS3-NS4A protease inhibition
|
TW201424733A
(zh)
|
2004-10-29 |
2014-07-01 |
Vertex Pharma |
劑量型式
|
EP1858877B1
(en)
*
|
2005-01-14 |
2014-03-12 |
Gilead Connecticut, Inc. |
1,3 substituted diaryl ureas as modulators of kinase activity
|
AU2006204790B2
(en)
*
|
2005-01-14 |
2012-08-23 |
Gilead Connecticut, Inc. |
1,3-diaryl substituted ureas as modulators of kinase activity
|
WO2006086500A2
(en)
*
|
2005-02-08 |
2006-08-17 |
Aspreva Pharmaceuticals Sa |
Compositions and methods for treating vascular, autoimmune and inflammatory diseases
|
US20060235009A1
(en)
*
|
2005-02-08 |
2006-10-19 |
Richard Glickman |
Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
|
KR101335932B1
(ko)
|
2005-03-07 |
2013-12-04 |
바이엘 헬스케어 엘엘씨 |
암의 치료를 위한 오메가-카르복시아릴 치환된 디페닐우레아를 포함하는 제약 조성물
|
US7777040B2
(en)
*
|
2005-05-03 |
2010-08-17 |
Cgi Pharmaceuticals, Inc. |
Certain substituted ureas, as modulators of kinase activity
|
AU2006244204A1
(en)
*
|
2005-05-09 |
2006-11-16 |
Vertex Pharmaceuticals Incorporated |
Polymorphic forms of (S)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate
|
KR20080015433A
(ko)
|
2005-05-09 |
2008-02-19 |
버텍스 파마슈티칼스 인코포레이티드 |
바이아릴 우레아 및 이의 유사체의 제조 방법
|
TWI383980B
(zh)
|
2005-07-29 |
2013-02-01 |
Tibotec Pharm Ltd |
C型肝炎病毒之大環抑制劑
|
CN101273027B
(zh)
|
2005-07-29 |
2015-12-02 |
爱尔兰詹森科学公司 |
丙型肝炎病毒的大环抑制剂
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
MY139988A
(en)
|
2005-07-29 |
2009-11-30 |
Tibotec Pharm Ltd |
Macrocylic inhibitors of hepatitis c virus
|
JO2768B1
(en)
|
2005-07-29 |
2014-03-15 |
تيبوتيك فارماسيوتيكالز ليمتد |
Large cyclic inhibitors of hepatitis C virus
|
WO2007014924A1
(en)
|
2005-07-29 |
2007-02-08 |
Tibotec Pharmaceuticals Ltd. |
Macrocyclic inhibitors of hepatitis c virus
|
PE20070210A1
(es)
|
2005-07-29 |
2007-04-16 |
Tibotec Pharm Ltd |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
PL1912997T3
(pl)
|
2005-07-29 |
2012-02-29 |
Tibotec Pharm Ltd |
Makrocykliczne inhibitory wirusa zapalenia wątroby typu C
|
EP1919899B1
(en)
|
2005-07-29 |
2011-01-19 |
Tibotec Pharmaceuticals |
Macrocyclic inhibitors of hepatitis c virus
|
ES2401661T3
(es)
*
|
2005-08-02 |
2013-04-23 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de serina proteasas
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
AR055395A1
(es)
*
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
EP2392590A3
(en)
|
2005-11-11 |
2012-03-14 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
CA2643688A1
(en)
|
2006-02-27 |
2007-08-30 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
KR20080112303A
(ko)
|
2006-03-16 |
2008-12-24 |
버텍스 파마슈티칼스 인코포레이티드 |
중수소화 c형 간염 프로테아제 억제제
|
BRPI0710878A2
(pt)
|
2006-04-11 |
2015-03-31 |
Novartis Ag |
Compostos orgânicos e seus usos
|
EP2066642A1
(en)
*
|
2006-09-25 |
2009-06-10 |
Arete Therapeutics, INC. |
Soluble epoxide hydrolase inhibitors
|
ES2535212T3
(es)
|
2006-10-04 |
2015-05-06 |
Janssen Sciences Ireland Uc |
Carboxamido-4-[(4-piridil)amino]-pirimidinas para el tratamiento de la hepatitis C
|
JP2010510192A
(ja)
|
2006-11-17 |
2010-04-02 |
テイボテク・フアーマシユーチカルズ・リミテツド |
C型肝炎ウイルスの大環状阻害剤
|
KR20090115970A
(ko)
*
|
2007-02-27 |
2009-11-10 |
버텍스 파마슈티칼스 인코포레이티드 |
공-결정 및 그를 포함하는 제약 조성물
|
CA2679426A1
(en)
*
|
2007-02-27 |
2008-09-04 |
Luc Farmer |
Inhibitors of serine proteases
|
US8143293B2
(en)
*
|
2007-04-20 |
2012-03-27 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases
|
EP2494991A1
(en)
|
2007-05-04 |
2012-09-05 |
Vertex Pharmaceuticals Incorporated |
Combination therapy for the treatment of HCV infection
|
JP5443360B2
(ja)
*
|
2007-08-30 |
2014-03-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
共結晶体およびそれを含む医薬組成物
|
BRPI0821836A2
(pt)
|
2007-12-24 |
2015-06-16 |
Tibotec Pharm Ltd |
Indóis macrocíclicos como inibidores do vírus da hepatite c
|
TWI454476B
(zh)
|
2008-07-08 |
2014-10-01 |
Tibotec Pharm Ltd |
用作c型肝炎病毒抑制劑之巨環吲哚衍生物
|
BRPI0917830A8
(pt)
|
2008-08-14 |
2016-07-26 |
Tibotec Pharm Ltd |
derivados de indol macrocíclicos úteis como inibidores do vírus da hepatite c
|
KR20110098779A
(ko)
|
2008-12-03 |
2011-09-01 |
프레시디오 파마슈티칼스, 인코포레이티드 |
Hcv ns5a의 억제제
|
EP2373172B1
(en)
|
2008-12-03 |
2013-07-17 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a
|
WO2010093843A2
(en)
|
2009-02-12 |
2010-08-19 |
Vertex Pharmaceuticals Incorporated |
Hcv combination therapies
|
US8969342B2
(en)
|
2009-03-20 |
2015-03-03 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
BRPI1012282A2
(pt)
|
2009-03-27 |
2015-09-22 |
Presidio Pharmaceuticals Inc |
inibidores de anel fundidos da hepatite c.
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
WO2011014882A1
(en)
|
2009-07-31 |
2011-02-03 |
Medtronic, Inc. |
CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-α TO HEPATITIS C INFECTED PATIENTS
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
RU2012136824A
(ru)
|
2010-01-29 |
2014-03-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способы лечения вирусной инфекции гепатита с
|
WO2011112516A1
(en)
|
2010-03-08 |
2011-09-15 |
Ico Therapeutics Inc. |
Treating and preventing hepatitis c virus infection using c-raf kinase antisense oligonucleotides
|
EP2575866A4
(en)
|
2010-05-24 |
2013-10-16 |
Presidio Pharmaceuticals Inc |
HCV NS5A INHIBITORS
|
NZ789041A
(en)
|
2010-06-03 |
2023-09-29 |
Pharmacyclics Llc |
The use of inhibitors of bruton’s tyrosine kinase (btk)
|
WO2011156545A1
(en)
|
2010-06-09 |
2011-12-15 |
Vertex Pharmaceuticals Incorporated |
Viral dynamic model for hcv combination therapy
|
US9127010B2
(en)
|
2010-06-24 |
2015-09-08 |
Janssen Sciences Ireland Uc |
Preparation of 13-cyclohexyl-3-methoxy-6-[methyl-(2-{2-[methyl-(sulphamoyl)-amino]-ethoxy}-ethyl)-carbamoyl]-7H-indolo-[2,1-a]-[2]-benzazepine-10-carboxylic acid
|
TW201208704A
(en)
|
2010-07-14 |
2012-03-01 |
Vertex Pharma |
Palatable pharmaceutical composition
|
AR082619A1
(es)
|
2010-08-13 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores del virus de la hepatitis c
|
WO2012109646A1
(en)
|
2011-02-11 |
2012-08-16 |
Vertex Pharmaceuticals Incorporated |
Treatment of hcv in hiv infection patients
|
CN102985104A
(zh)
|
2011-02-25 |
2013-03-20 |
麦德托尼克公司 |
在干扰素-α治疗方案中使用药代动力学分布和药效动力学分布的方法和系统
|
WO2012123298A1
(en)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
CN103732242A
(zh)
|
2011-06-23 |
2014-04-16 |
迪格纳生物技术公司 |
用与IFN-α2b组合的IFN-α5在患者群体中治疗慢性丙型肝炎
|
US20120328565A1
(en)
|
2011-06-24 |
2012-12-27 |
Brinkman John A |
Antiviral compounds
|
MX2014003705A
(es)
|
2011-10-10 |
2014-07-22 |
Hoffmann La Roche |
Compuestos antivirales.
|
JP5923181B2
(ja)
|
2011-12-16 |
2016-05-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Hcvns5aの阻害剤
|
SI2794629T1
(sl)
|
2011-12-20 |
2017-10-30 |
Riboscience Llc |
2'4'-difluoro-2'-metil substituirani nukleozidni derivati k0t zaviralci replikacije hcv-rna
|
AU2012357986B2
(en)
|
2011-12-20 |
2017-02-02 |
Riboscience Llc |
4'-Azido, 3'-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
|
AU2012360905B2
(en)
|
2011-12-28 |
2017-04-27 |
Janssen Sciences Ireland Uc |
Hetero-bicyclic derivatives as HCV inhibitors
|
WO2013116339A1
(en)
|
2012-01-31 |
2013-08-08 |
Vertex Pharmaceuticals Incorporated |
High potency formulations of vx-950
|
CN104185624B
(zh)
|
2012-02-24 |
2016-10-12 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒化合物
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US20140010783A1
(en)
|
2012-07-06 |
2014-01-09 |
Hoffmann-La Roche Inc. |
Antiviral compounds
|
EP2877598A1
(en)
|
2012-07-24 |
2015-06-03 |
Pharmacyclics, Inc. |
Mutations associated with resistance to inhibitors of bruton's tyrosine kinase (btk)
|
US9447134B2
(en)
|
2012-08-17 |
2016-09-20 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
US20140205566A1
(en)
|
2012-11-30 |
2014-07-24 |
Novartis Ag |
Cyclic nucleuoside derivatives and uses thereof
|
CN105073726B
(zh)
|
2013-01-23 |
2017-05-31 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒三唑衍生物
|
WO2014135422A1
(en)
|
2013-03-05 |
2014-09-12 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
US20180200280A1
(en)
|
2013-05-16 |
2018-07-19 |
Riboscience Llc |
4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
|
BR112015028764B1
(pt)
|
2013-05-16 |
2022-09-27 |
Riboscience Llc |
Derivados de nucleosídeo de 4-fluoro-2-metil substituídos como inibidores de replicação de rna do hcv
|
SG11201509427RA
(en)
|
2013-05-16 |
2015-12-30 |
Riboscience Llc |
4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives
|
WO2015061752A1
(en)
|
2013-10-25 |
2015-04-30 |
Pharmacyclics, Inc. |
Treatment using bruton's tyrosine kinase inhibitors and immunotherapy
|
WO2015143400A1
(en)
|
2014-03-20 |
2015-09-24 |
Pharmacyclics, Inc. |
Phospholipase c gamma 2 and resistance associated mutations
|
SG11202002431SA
(en)
|
2017-09-21 |
2020-04-29 |
Riboscience Llc |
4'-fluoro-2'-methyl substituted nucleoside derivatives as inhibitors of hcv rna replication
|
CN111818915B
(zh)
|
2018-01-31 |
2024-05-24 |
德西费拉制药有限责任公司 |
治疗胃肠道间质瘤的组合疗法
|
CA3094324A1
(en)
|
2018-03-26 |
2019-10-03 |
Clear Creek Bio, Inc. |
Compositions and methods for inhibiting dihydroorotate dehydrogenase
|
CN109970675A
(zh)
*
|
2018-05-28 |
2019-07-05 |
中国医学科学院医药生物技术研究所 |
一组硫脲化合物及其制备方法和应用
|
KR20210022645A
(ko)
|
2018-06-19 |
2021-03-03 |
노파르티스 아게 |
N-치환된 테트라히드로티에노피리딘 유도체 및 이의 용도
|
EP4013412A1
(en)
|
2019-08-12 |
2022-06-22 |
Deciphera Pharmaceuticals, LLC |
Ripretinib for treating gastrointestinal stromal tumors
|
WO2021030405A1
(en)
|
2019-08-12 |
2021-02-18 |
Deciphera Pharmaceuticals, Llc |
Ripretinib for treating gastrointestinal stromal tumors
|
CN110590535A
(zh)
*
|
2019-10-12 |
2019-12-20 |
重庆医药高等专科学校 |
用二氧化硒氧化芳香乙酮制备芳香乙醛酸的方法
|
EP4084779A1
(en)
|
2019-12-30 |
2022-11-09 |
Deciphera Pharmaceuticals, LLC |
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
|
KR20220123057A
(ko)
|
2019-12-30 |
2022-09-05 |
데시페라 파마슈티칼스, 엘엘씨. |
비정질 키나아제 억제제 제형 및 이의 사용 방법
|
WO2021209563A1
(en)
|
2020-04-16 |
2021-10-21 |
Som Innovation Biotech, S.A. |
Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|